Pharmacology, Toxicology and Pharmaceutical Science
Small Interfering RNA
100%
Malignant Neoplasm
85%
Polycation
67%
Gene Delivery
65%
Copolymer
55%
Nanoparticle
53%
Neoplasm
44%
Nucleic Acid
41%
Polyamine
26%
Chloroquine
25%
Poly(amidoamine)
25%
N-(2-Hydroxypropyl) Methacrylamide
24%
Plerixafor
23%
Pancreas Cancer
23%
Disease
23%
Polyelectrolyte
21%
Lysine
20%
Breast Cancer
19%
Acute Kidney Failure
18%
Mouse
17%
Chemokine Receptor CXCR4 Antagonist
16%
Cytotoxicity
16%
Disulfide
15%
Polymer
15%
Thiol
15%
Atomic Force Microscopy
14%
Macrogol
14%
Tumor Microenvironment
14%
Methacrylate
13%
Pharmacokinetics
13%
microRNA
12%
Liposome
11%
Photothermal Therapy
11%
Prodrug
11%
Chemokine Receptor CXCR4
11%
Polyethyleneimine
11%
Nanogel
11%
Nanoemulsion
11%
Plasmid DNA
11%
Biodistribution
10%
Anticarcinogen
10%
Gene Delivery
10%
Chemokine
10%
Dextrin
10%
Systemic Circulation
9%
Lung Metastasis
9%
Aziridine
9%
Doxorubicin
9%
Combination Therapy
9%
PEGylation
8%
Keyphrases
Small Interfering RNA (siRNA)
15%
Biodegradable Polycation
13%
Polyplexes
13%
Chloroquine
11%
Control Topology
11%
DNA Nanoparticles
11%
Gene Delivery Vector
11%
Nanoparticles
11%
Pancreatic Cancer
11%
Nanoemulsion
10%
Gene Silencing
9%
C-X-C Chemokine Receptor Type 4 (CXCR4)
9%
DNA Release
8%
Release Dynamics
8%
Copolymer
8%
Polycation
8%
CXCR4 Inhibitor
8%
CXCR4 Antagonist
7%
Simultaneous Quantitation
7%
Nanofilm
7%
Steric Stabilization
7%
Lateral Stabilization
7%
Cancer Cell Migration
7%
AFM Analysis
7%
Nanoparticle Films
7%
Redox-responsive
7%
Hypoxia-activated Therapy
7%
Inflammatory Bowel Disease
7%
Nanosystems
7%
Small Interfering RNA (siRNA) Delivery
7%
Biological Characterization
7%
Hydroxychloroquine
6%
Autophagy
5%
Combination Treatment
5%
In Situ AFM
5%
Tumor Microenvironment
5%
Lung
5%
PHPMA
5%
Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS)
5%
Tumor
5%
Atomic Force Microscope
5%
Pulmonary Delivery
5%
Perfluorocarbon Emulsion
5%
Macromolecular Drugs
5%
Layer-by-layer Film
5%
